Literature DB >> 31081850

Screening Options for Preventing Cervical Cancer.

Sarah Feldman1,2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31081850     DOI： 10.1001/jamainternmed.2019.0298

Source DB:  PubMed          Journal:  JAMA Intern Med        ISSN： 2168-6106            Impact factor:   21.873


× No keyword cloud information.
  4 in total

1.  Verification of the association of the cycle threshold (Ct) values from HPV testing on Cobas4800 with the histologic grades of cervical lesions using data from two population-based cervical cancer screening trials.

Authors:  Yi Zhang; Hui Du; Aimin Xiao; Wei Zhang; Chun Wang; Xia Huang; Xinfeng Qu; Jianliu Wang; Ruifang Wu
Journal:  Infect Agent Cancer       Date:  2022-06-11       Impact factor: 3.698

2.  Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.

Authors:  Jin Qin; Shahram Shahangian; Mona Saraiya; Hunter Holt; Maribeth Gagnon; George F Sawaya
Journal:  Gynecol Oncol       Date:  2021-09-08       Impact factor: 5.482

3.  Long noncoding RNA HCG11 inhibited growth and invasion in cervical cancer by sponging miR-942-5p and targeting GFI1.

Authors:  Yan Zhang; Jun Zhang; Lin Mao; Xing Li
Journal:  Cancer Med       Date:  2020-08-13       Impact factor: 4.452

4.  Adenosquamous Carcinoma of the Cervix: A Population-Based Analysis.

Authors:  Pengfei Cui; Xiaofeng Cong; Chen Chen; Lei Yang; Ziling Liu
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.